From the Medriva Blog Revolutionizing Digital Pathology with Deep Learning In the rapidly evolving landscape of healthcare and medicine, artificial intelligence (AI) and deep learning (DL) techniques are emerging as transformative tools,...

A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing with deep learning. Their AI-based...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company specializing in AI-powered pathology solutions, released its first AI algorithm in its Mitosis product family: Aiosyn Mitosis Research. The innovative deep-learning...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to...

PathAI: Latest research underscores advantages of digital tools at scale to enhance tumor microenvironment and biomarker understanding in non-small cell lung cancer and renal cell carcinoma BOSTON, Mass., April 11, 2023 /PRNewswire/...

PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...